Depleted tumor suppressor miR-107 in plasma relates to tumor progression and is a novel therapeutic target in pancreatic cancer

This study explored decreased tumor suppressor microRNA (miRNA) plasma levels in pancreatic cancer (PCa) patients to clarify their potential as novel biomarkers and therapeutic targets. We used the microRNA array-based approach to select candidates by comparing plasma levels between PCa patients and...

Descripción completa

Detalles Bibliográficos
Autores principales: Imamura, Taisuke, Komatsu, Shuhei, Ichikawa, Daisuke, Miyamae, Mahito, Okajima, Wataru, Ohashi, Takuma, Kiuchi, Jun, Nishibeppu, Keiji, Konishi, Hirotaka, Shiozaki, Atsushi, Morimura, Ryo, Ikoma, Hisashi, Ochiai, Toshiya, Okamoto, Kazuma, Taniguchi, Hiroki, Otsuji, Eigo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2017
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5515843/
https://www.ncbi.nlm.nih.gov/pubmed/28720759
http://dx.doi.org/10.1038/s41598-017-06137-8

Ejemplares similares

Ejemplares similares